Fresenius SE & Co. KGaA (VIE:FRE)

Austria flag Austria · Delayed Price · Currency is EUR
50.68
+1.43 (2.90%)
At close: Jan 12, 2026
46.56%
Market Cap28.86B
Revenue (ttm)22.45B
Net Income (ttm)1.14B
Shares Outn/a
EPS (ttm)2.03
PE Ratio25.25
Forward PE14.00
Dividend1.00 (1.97%)
Ex-Dividend DateMay 26, 2025
Volumen/a
Average Volume113
Open49.65
Previous Close49.25
Day's Range49.65 - 50.68
52-Week Range34.58 - 50.68
Betan/a
RSI71.45
Earnings DateMar 25, 2026

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 1912
Employees 176,486
Stock Exchange Vienna Stock Exchange
Ticker Symbol FRE
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.